Telementoring for Diabetes Care Improvement

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byElizabeth Vaughan, DO

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: The University of Texas Medical Branch, Galveston

No Placebo Group

Trial Summary

What is the purpose of this trial?Diabetes care is complex and requires a multidimensional approach, but interventional programs are difficult to initiate in low-income and minority populations. In the proposed study, investigators will mentor local clinics via telehealth to initiate our diabetes program involving telehealth-support, integrated CHWs, medication-access, and diabetes Education into their clinics. Mentoring local clinics to initiate this intervention is a promising strategy to enhance sustainable diabetes care and reduce disparities in vulnerable minority populations.

Eligibility Criteria

This trial is for Spanish-speaking adults over 18 with type 2 diabetes, an HbA1c level of at least 6.5%, and taking oral diabetes medication. Participants must be uninsured, below the poverty line, and self-identify as Latino(a). It's not for those who miss group visits, have conditions affecting HbA1c levels or need frequent clinic visits.

Inclusion Criteria

I have type 2 diabetes with an HbA1c level of 6.5% or higher and am taking oral medication for it.

I speak Spanish.

Uninsured and below 150% of the federal poverty level

+2 more

Exclusion Criteria

No show to all group visits

You are not able to receive care in a group setting, such as if you are pregnant or have severe memory or thinking problems.

You have a condition that may change your HbA1c levels, like having had a recent blood transfusion.

Participant Groups

The study tests a telementoring program called TIME that helps local clinics start a comprehensive diabetes care initiative. The focus is on integrating community health workers (CHWs), improving medication access, and providing group education through telehealth support.

2Treatment groups

Experimental Treatment

Group I: Usual Care (UC)Experimental Treatment1 Intervention

We will define UC as usual clinical care, which consists of diabetes management provider encounters (mean quarterly) plus monthly individual appointments with a pharm-Ds or nutritionists as clinically indicated. In addition, clinics offer multiple other individual and group opportunities.

Group II: InterventionExperimental Treatment1 Intervention

Intervention individuals will receive the 12-month diabetes program